Published in EMBO J on March 01, 1984
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest (1991) 2.08
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol (1992) 1.95
The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol (1989) 1.91
Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc Natl Acad Sci U S A (1989) 1.57
A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J (1988) 1.42
Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc Natl Acad Sci U S A (1988) 1.41
Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect Immun (1994) 1.31
DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci U S A (1996) 1.28
Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol (1997) 1.27
Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci U S A (1995) 1.19
Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol (2007) 1.06
Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci U S A (1986) 0.99
Easing the global burden of diarrhoeal disease: can synthetic biology help? Syst Synth Biol (2013) 0.98
The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection. Clin Exp Immunol (1990) 0.98
Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. J Virol (2006) 0.96
Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proc Natl Acad Sci U S A (1989) 0.94
Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus. Immunology (1987) 0.81
Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein. J Virol (1993) 0.80
Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus. Appl Environ Microbiol (2014) 0.78
Phage display creates innovative applications to combat hepatitis B virus. World J Gastroenterol (2014) 0.77
Chimeric Rabbit/Human Fab Antibodies Against the Hepatitis B e-antigen and Their Potential Applications in Assay, Characterization and Therapy. J Biol Chem (2017) 0.75
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. Stud Hist Philos Biol Biomed Sci (2017) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med (1980) 9.34
New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol (1972) 6.33
Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature (1979) 6.10
Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A (1979) 4.71
e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med (1976) 4.01
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A (1980) 3.97
Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh (1968) 3.90
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature (1982) 3.82
Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62
Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci U S A (1981) 3.38
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis (1977) 2.80
Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines. J Mol Biol (1982) 2.75
The genome of hepatitis B virus. Annu Rev Microbiol (1977) 2.31
Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A (1982) 2.20
Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc Natl Acad Sci U S A (1982) 2.19
The conversion of hepatitis B core antigen synthesized in E coli into e antigen. J Med Virol (1981) 2.11
Two yeast acid phosphatase structural genes are the result of a tandem duplication and show different degrees of homology in their promoter and coding sequences. EMBO J (1982) 2.09
Letter: Infectivity of serum containing HBsAg and antibody to e antigen. Lancet (1976) 1.56
Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res (1983) 1.39
A sensitive immunoradiometric assay for the detection of hepatitis B surface antigen. J Virol Methods (1980) 1.30
Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol (1976) 1.25
Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med (1982) 1.24
Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy. J Med Virol (1982) 1.16
Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.16
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis (1983) 1.08
Demonstration of hepatitis B e antigen (HBeAg) in association with intact Dane particles. J Gen Virol (1979) 0.97
Characterization of 'e' antigen associated with hepatitis B. Clin Exp Immunol (1979) 0.93
Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers. J Clin Pathol (1977) 0.88
Transformation of yeast. Proc Natl Acad Sci U S A (1978) 46.46
A specific endonuclease from Arthrobacter luteus. J Mol Biol (1976) 25.89
Lambdoid phages that simplify the recovery of in vitro recombinants. Mol Gen Genet (1977) 16.76
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
Phage lambda receptor chromosomes for DNA fragments made with restriction endonuclease III of Haemophilus influenzae and restriction endonuclease I of Escherichia coli. J Mol Biol (1975) 10.57
Metabolism of benzoate and the methylbenzoates by Pseudomonas putida (arvilla) mt-2: evidence for the existence of a TOL plasmid. J Bacteriol (1974) 9.37
Packaging recombinant DNA molecules into bacteriophage particles in vitro. Proc Natl Acad Sci U S A (1977) 7.42
Manipulation of restriction targets in phage lambda to form receptor chromosomes for DNA fragments. Nature (1974) 7.22
Recognition sequence of restriction endonuclease III from Hemophilus influenzae. J Mol Biol (1975) 6.23
Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements. EMBO J (1986) 6.09
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
The metabolism of benzoate and methylbenzoates via the meta-cleavage pathway by Pseudomonas arvilla mt-2. Eur J Biochem (1972) 5.98
Molecular cloning of the DNA ligase gene from bacteriophage T4. II. Amplification and preparation of the gene product. J Mol Biol (1979) 5.86
Recognition sequence of a restriction enzyme. Nat New Biol (1973) 5.14
Nucleotide sequence analysis with polynucleotide kinase and nucleotide "mapping" methods. 5'-Terminal sequences of deoxyribonucleic acid from bacteriophages lambda and 424. Biochem J (1973) 4.86
Infection of humans and horses by a newly described morbillivirus. Med J Aust (1995) 4.68
The metabolic divergence in the meta cleavage of catechols by Pseudomonas putida NCIB 10015. Physiological significance and evolutionary implications. Eur J Biochem (1972) 4.16
Properties of yeast transformation. Cold Spring Harb Symp Quant Biol (1979) 4.05
The hepatitis delta (delta) virus possesses a circular RNA. Nature (1986) 4.00
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol (1993) 3.68
Inhibitory control in young children and its role in emerging internalization. Child Dev (1996) 3.60
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Inhibitory control as a contributor to conscience in childhood: from toddler to early school age. Child Dev (1997) 3.16
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys (2000) 3.00
Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature (1988) 2.99
Nucleotide 'maps' of digests of deoxyribonucleic acid. Biochem J (1970) 2.95
Infectivity in mouse fibroblasts of polyoma DNA integrated into plasmid pBR322 or lambdoid phage DNA. Nature (1979) 2.92
A specific endonuclease from Haemophilus haemolyticus. J Mol Biol (1976) 2.92
Dental practitioners and ill health retirement: causes, outcomes and re-employment. Br Dent J (2010) 2.83
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Restriction and modification in B. subtilis. Purification and general properties of a restriction endonuclease from strain R. Mol Gen Genet (1975) 2.79
Role of catechol and the methylcatechols as inducers of aromatic metabolism in Pseudomonas putida. J Bacteriol (1974) 2.78
Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines. J Mol Biol (1982) 2.75
The sequence of the Saccharomyces cerevisiae gene PHO2 codes for a regulatory protein with unusual aminoacid composition. Nucleic Acids Res (1987) 2.69
The two positively acting regulatory proteins PHO2 and PHO4 physically interact with PHO5 upstream activation regions. Mol Cell Biol (1989) 2.60
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
Suppression of malignancy and differentiation in melanotic melanoma cells. Proc Natl Acad Sci U S A (1970) 2.44
The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J Gen Virol (1986) 2.29
Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic approach. Mol Gen Genet (1999) 2.26
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Restriction and modification in B. subtilis. Nucleotide sequence recognised by restriction endonuclease R. Bsu R from strain R. Mol Gen Genet (1975) 2.20
Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc Natl Acad Sci U S A (1982) 2.19
Structural analysis of the two tandemly repeated acid phosphatase genes in yeast. Nucleic Acids Res (1984) 2.17
Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) (1993) 2.12
The yeast PHO5 promoter: phosphate-control elements and sequences mediating mRNA start-site selection. Proc Natl Acad Sci U S A (1987) 2.12
The conversion of hepatitis B core antigen synthesized in E coli into e antigen. J Med Virol (1981) 2.11
Two yeast acid phosphatase structural genes are the result of a tandem duplication and show different degrees of homology in their promoter and coding sequences. EMBO J (1982) 2.09
Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol (1991) 2.02
Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet (1988) 1.95
Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Nat Biotechnol (1998) 1.95
Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94
Anisotropic rotational diffusion of perdeuterated HIV protease from 15N NMR relaxation measurements at two magnetic fields. J Biomol NMR (1996) 1.94
One-step gene replacement in yeast by cotransformation. Gene (1985) 1.93
Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol (1988) 1.92
The 3'-terminal nucleotide sequences of bacteriophage lambda DNA. Proc Natl Acad Sci U S A (1973) 1.92
Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. Eur J Biochem (1986) 1.89
Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell (1983) 1.87
Microbial metabolism of aryl sulphonates a re-assessment of colorimetric methods for the determination of sulphite and their use in measuring desulphonation of aryl and alkylbenzene sulphonates. Antonie Van Leeuwenhoek (1975) 1.87
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys (2001) 1.76
Terminal nucleotide sequences of DNA from temperate coliphages. Nat New Biol (1973) 1.76
Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology (1977) 1.75
Dental practitioners and ill health retirement: a qualitative investigation into the causes and effects. Br Dent J (2010) 1.74
Yeast H3 and H4 histone messenger RNAs are transcribed from two non-allelic gene sets. J Mol Biol (1983) 1.72
Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J (1984) 1.69
Restriction of bacteriophage lambda by Escherichia coli K. J Mol Biol (1973) 1.68
Interpathway regulation of the TRP4 gene of yeast. EMBO J (1989) 1.65
Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.65
Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol (1995) 1.63
Isolation and characterization of two sequence-specific endonucleases from Anabaena variabilis. Biochem J (1976) 1.62
Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods (1985) 1.62
A deletion that includes the signal peptidase cleavage site impairs processing, glycosylation, and secretion of cell surface yeast acid phosphatase. Mol Cell Biol (1984) 1.61
Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc Natl Acad Sci U S A (1989) 1.57
Cloning and expression of a cDNA for human thioredoxin. J Biol Chem (1988) 1.55
The configuration of the 1,2-dihydroxy-1,2-dihydronaphthalene formed in the bacterial metabolism of naphthalene. Biochim Biophys Acta (1971) 1.51
Experiences and expectations of refugee doctors: Qualitative study. Br J Psychiatry (2006) 1.49
ACUTE PANCREATIC NECROSIS : (A review of twenty cases). Can Med Assoc J (1934) 1.48
Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology (1989) 1.47
Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J (1985) 1.47
Oestrogen status in relation to the early training responses in human thumb adductor muscles. Acta Physiol (Oxf) (2006) 1.46
Clean intermittent self-catheterisation in the management of adult lower urinary tract dysfunction. Br J Urol (1984) 1.45
Social and gender variation in the prevalence, presentation and general practitioner provisional diagnosis of chest pain. J Epidemiol Community Health (2000) 1.44
A specific endonuclease from Brevibacterium albidum. J Mol Biol (1977) 1.43
IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol (1996) 1.42
Hazelnut allergy differs between children and adults in frequency of severity, aetiology and relevance of diagnostic parameters. Clin Exp Allergy (2014) 1.41
Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A (1990) 1.39
[Pulmonary infection with Coccidioides immitis]. Ned Tijdschr Geneeskd (1996) 1.39
Inadequacies in the Mental Health Act, 1983 in relation to mentally disordered remand prisoners. Med Sci Law (1997) 1.39
[Neurological complications of infectious mononucleosis in 3 patients]. Ned Tijdschr Geneeskd (1994) 1.37
Metabolism of naphthalene, 2-methylnaphthalene, salicylate, and benzoate by Pseudomonas PG: regulation of tangential pathways. J Bacteriol (1975) 1.36
Maternal reports of conscience development and temperament in young children. Child Dev (1994) 1.36